Skip to main content
VCbacked
Log inGet Started

CV6 Therapeutics

Belfast, United Kingdom

CV6 Therapeutics is a drug development company focused on the discovery, development and commercialization of novel therapies.

$5.7M raised
Nov 2022
Venture - Series Unknown
BiotechnologyHealth CarePharmaceutical

Top Investors

Clarendon Fund ManagersTechstart VenturesQUBISInvest Northern IrelandCo-FundNI

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about CV6 Therapeutics

How much funding has CV6 Therapeutics raised?
CV6 Therapeutics has raised $5.7M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in November 2022.
Who are CV6 Therapeutics's investors?
CV6 Therapeutics's investors include Clarendon Fund Managers, Techstart Ventures, QUBIS, Invest Northern Ireland, Co-FundNI.
Where is CV6 Therapeutics headquartered?
CV6 Therapeutics is headquartered in Belfast, United Kingdom.
What does CV6 Therapeutics do?
CV6 Therapeutics is a drug development company focused on the discovery, development and commercialization of novel therapies.
What stage is CV6 Therapeutics at?
CV6 Therapeutics is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"CV6 Therapeutics — Funding & Investors." VCBacked, November 2, 2022, https://www.vcbacked.co/company/cv6-therapeutics. Accessed July 2, 2026.
APA
VCBacked. (2022). CV6 Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/cv6-therapeutics
Wikipedia (cite web)
{{cite web |title=CV6 Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/cv6-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Renaissance BioScience
Vancouver$599K
Allterum Therapeutics
Houston$1.0M
Rapport Therapeutics
Boston$250.0M
AlpalifeBio
Woburn$9.8M
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K